arginylproline has been researched along with Urinary Bladder Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fernández-Pérez, C; Garde-García, H; Maestro-de Las Casas, M; Moreno-Sierra, J; Redondo-González, E | 1 |
1 other study(ies) available for arginylproline and Urinary Bladder Neoplasms
Article | Year |
---|---|
Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications.
Topics: Aged; Analysis of Variance; Biomarkers, Tumor; Codon; Dipeptides; Disease Progression; Female; Genes, p53; Genes, ras; Genetic Markers; Humans; Male; Microsatellite Instability; Microsatellite Repeats; Neoplasm Recurrence, Local; Point Mutation; Prognosis; Prospective Studies; Sex Factors; Time Factors; Urinary Bladder Neoplasms | 2021 |